Trial intelligence / Profile preview

Effects of maternal intranasal oxytocin on social information processing in mothers and infants

2014-005431-13Phase 4Completed

Sponsor
Tampere University Hospital
Start
Dec 2014
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial comparing Intranasal Syntocinon with Placebo nasal spray (2 arms). Primary endpoint: Maternal sensitivity on Emotional Availability Scales. Started Dec 2014; status: completed.

02

Drugs

oxytocin

Beyond the preview

Go deeper on 2014-005431-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005431-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call